Patents by Inventor Yanan GUO

Yanan GUO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-TNFRSF9 ANTIBODIES AND USES THEREOF
    Publication number: 20240092922
    Abstract: This disclosure relates to anti-TNFRSF9 (tumor necrosis factor receptor superfamily member 9) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Application
    Filed: September 11, 2023
    Publication date: March 21, 2024
    Inventors: Yi Yang, Jingshu Xie, Chunyan Dong, Fang Yang, Chengyuan Lu, Yuelei Shen, Jian Ni, Yanan Guo, Yunyun Chen
  • METHOD, SYSTEM AND STORAGE MEDIUM FOR SOLID-PHASE CONCENTRATION CORRECTION OF LITHIUM BATTERIES
    Publication number: 20230417834
    Abstract: The invention discloses a method, a system and a storage medium for solid-phase concentration correction of a lithium battery.
    Type: Application
    Filed: June 12, 2023
    Publication date: December 28, 2023
    Inventors: Pingchao Hao, Zhiyi Zhang, Yanan Guo, Xiao Yan, Enhai Zhao, Zhou Yang, Zhimin Zhou, Xiaohua Chen
  • GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC GLP1R
    Publication number: 20230363362
    Abstract: This disclosure relates to genetically modified animal expressing human or chimeric (e.g., humanized) GLP1R, and methods of use thereof.
    Type: Application
    Filed: September 17, 2021
    Publication date: November 16, 2023
    Inventors: Yuelei Shen, Jiawei Yao, Yanan Guo, Yang Bai, Chengzhang Shang
  • METHOD, STORAGE MEDIUM AND APPARATUS FOR ADJUSTING CHARGING-DISCHARGING EFFICIENCY RATIO OF ENERGY STORAGE POWER STATION
    Publication number: 20230361593
    Abstract: The invention provides method, apparatus and storage medium for adjusting the charging-discharging efficiency ratio of an energy storage power station.
    Type: Application
    Filed: April 26, 2023
    Publication date: November 9, 2023
    Inventors: Pei Song, Zhiyi Zhang, Yanan Guo, Danfei Gu, Pingchao Hao, Peng Ding, Weikun Wu, Guopeng Zhou, Wenfu Wang, Xiao Yan, Enhai Zhao, Xiaohua Chen
  • Genetically modified mice expressing humanized CD47
    Patent number: 11723348
    Abstract: The present disclosure relates to genetically modified non-human animals that express a human or chimeric (e.g., humanized) CD47, and methods of use thereof.
    Type: Grant
    Filed: November 2, 2020
    Date of Patent: August 15, 2023
    Assignee: Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
    Inventors: Yuelei Shen, Yang Bai, Jian Ni, Rui Huang, Chengzhang Shang, Yanan Guo
  • GENETICALLY MODIFIED NON-HUMAN ANIMAL EXPRESSING A B2M/FCRN FUSION PROTEIN
    Publication number: 20230227531
    Abstract: The present disclosure relates to genetically modified non-human animals that express a fusion protein including B2M and FcRn, and methods of use thereof. In some embodiments, the animals can have a B-NDG background. In some embodiments, the endogenous B2M gene is knocked out in the animals.
    Type: Application
    Filed: June 18, 2021
    Publication date: July 20, 2023
    Inventors: Yuelei Shen, Jiawei Yao, Yanan Guo, Yang Bai, Chengzhang Shang
  • GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC CD276
    Publication number: 20230165227
    Abstract: The present disclosure relates to genetically modified non-human animals that express a human or chimeric (e.g., humanized) CD276, and methods of use thereof.
    Type: Application
    Filed: May 21, 2021
    Publication date: June 1, 2023
    Inventors: Yuelei Shen, Yang Bai, Jiawei Yao, Yanan Guo, Lei Zhao
  • GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC CD38
    Publication number: 20230148574
    Abstract: The present disclosure relates to genetically modified non-human animals that express a human or chimeric (e.g., humanized) CD38, and methods of use thereof.
    Type: Application
    Filed: April 1, 2021
    Publication date: May 18, 2023
    Inventors: Yuelei Shen, Yang Bai, Jiawei Yao, Yanan Guo, Lei Zhao
  • GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC MHC PROTEIN COMPLEX
    Publication number: 20230072216
    Abstract: The present disclosure relates to genetically modified non-human animals that express a human or chimeric (e.g., humanized) major histocompatibility complex (MHC) protein complex, and methods of use thereof.
    Type: Application
    Filed: January 8, 2021
    Publication date: March 9, 2023
    Inventors: Yuelei Shen, Chaoshe Guo, Meiling Zhang, Rui Huang, Yanan Guo, Yang Bai, Jiawei Yao, Chengzhang Shang
  • GENETICALLY MODIFIED IMMUNODEFICIENT NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPa/CD47
    Publication number: 20230058049
    Abstract: This disclosure relates to genetically modified immunodeficient animals which express a human or chimeric (e.g., humanized) SIRP? and/or human or chimeric (e.g., humanized) CD47, and methods of use thereof.
    Type: Application
    Filed: December 31, 2020
    Publication date: February 23, 2023
    Inventors: Yuelei Shen, Yang Bai, Jiawei Yao, Chaoshe Guo, Meiling Zhang, Rui Huang, Yanan Guo, Chengzhang Shang
  • HUMANIZED TRANSGENIC ANIMAL
    Publication number: 20230043907
    Abstract: Provided are a humanized transgenic non-human animal, especially a rodent, in particular a transgenic mouse containing a human interleukin 17A (IL-17A) gene, a human gene 17RA (IL-17RA) and/or a human TNF-alpha gene, and a preparation method therefor and the use thereof.
    Type: Application
    Filed: August 1, 2022
    Publication date: February 9, 2023
    Inventors: Yuelei Shen, Chaoshe Guo, Yanan Guo, Yang Bai, Rui Huang, Lei Zhao, Xiaofei Zhou, Meiling Zhang, Jiawei Yao
  • Genetically modified non-human animal with human or chimeric LAG3
    Patent number: 11564381
    Abstract: The present disclosure relates to genetically modified non-human animals that express a human or chimeric (e.g., humanized) LAG3, and methods of use thereof.
    Type: Grant
    Filed: September 1, 2020
    Date of Patent: January 31, 2023
    Assignee: Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
    Inventors: Yuelei Shen, Jiawei Yao, Chaoshe Guo, Yanan Guo, Yang Bai, Rui Huang, Lei Zhao, Meiling Zhang
  • GENETICALLY MODIFIED NON-HUMAN ANIMALS WITH HUMAN OR CHIMERIC THPO
    Publication number: 20220408704
    Abstract: The present disclosure relates to genetically modified non-human animals expressing human or chimeric (e.g., humanized) Thrombopoietin (THPO), and methods of use thereof.
    Type: Application
    Filed: October 30, 2020
    Publication date: December 29, 2022
    Inventors: Yuelei Shen, Rui Huang, Yanan Guo, Yang Bai, Jiawei Yao, Chaoshe Guo, Meiling Zhang
  • Genetically modified non-human animal with human or chimeric TIGIT
    Patent number: 11534502
    Abstract: The present disclosure relates to the genetically modified non-human animals that express a human or chimeric TIGIT (e.g., humanized TIGIT), and methods of use thereof.
    Type: Grant
    Filed: August 30, 2017
    Date of Patent: December 27, 2022
    Assignee: Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
    Inventors: Yuelei Shen, Yang Bai, Rui Huang, Yanan Guo, Xiaofei Zhou, Meiling Zhang
  • GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC GENES
    Publication number: 20220378025
    Abstract: The present disclosure relates to genetically modified non-human animals that express a human or chimeric (e.g., humanized) IL10R and/or a human or chimeric (e.g., humanized) IL10, and methods of use thereof.
    Type: Application
    Filed: November 11, 2020
    Publication date: December 1, 2022
    Inventors: Yuelei Shen, Yanan Guo, Yang Bai, Jiawei Yao, Chaoshe Guo, Meiling Zhang, Rui Huang, Lei Zhao, Xiaofei Zhou
  • Genetically modified mice expressing humanized CD40
    Patent number: 11497198
    Abstract: The present disclosure relates to genetically modified non-human animals that express a human or chimeric (e.g., humanized) CD40, and methods of use thereof.
    Type: Grant
    Filed: June 7, 2019
    Date of Patent: November 15, 2022
    Assignee: Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
    Inventors: Yuelei Shen, Chaoshe Guo, Rui Huang, Lei Zhao, Yanan Guo, Yang Bai, Meiling Zhang, Jiawei Yao
  • GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC TNFR2
    Publication number: 20220346357
    Abstract: The present disclosure relates to genetically modified non-human animals that express a human or chimeric (e.g., humanized) TNFR2, and methods of use thereof.
    Type: Application
    Filed: September 4, 2020
    Publication date: November 3, 2022
    Inventors: Yuelei Shen, Rui Huang, Yanan Guo, Yang Bai, Lei Zhao, Jiawei Yao, Chaoshe Guo, Meiling Zhang
  • ANTI-PD-1 ANTIBODIES AND USES THEREOF
    Publication number: 20220324978
    Abstract: This disclosure relates to anti-PD-1 (Programmed Cell Death Protein 1) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Application
    Filed: April 20, 2022
    Publication date: October 13, 2022
    Inventors: Yi Yang, Chunyan Dong, Fang Yang, Chengyuan Lu, Yuelei Shen, Jian Ni, Yanan Guo, Yunyun Chen, Jingshu Xie
  • Genetically modified mouse comprising a chimeric TIGIT
    Patent number: 11464876
    Abstract: The present disclosure relates to the genetically modified non-human animals that express a human or chimeric TIGIT (e.g., humanized TIGIT), and methods of use thereof.
    Type: Grant
    Filed: May 31, 2019
    Date of Patent: October 11, 2022
    Assignee: Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
    Inventors: Yuelei Shen, Yang Bai, Rui Huang, Yanan Guo, Xiaofei Zhou, Meiling Zhang
  • GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC IL2RA
    Publication number: 20220312749
    Abstract: The present disclosure relates to genetically modified non-human animals that express a human or chimeric (e.g., humanized) IL2RA, and methods of use thereof.
    Type: Application
    Filed: August 7, 2020
    Publication date: October 6, 2022
    Inventors: Yuelei Shen, Yang Bai, Chengzhang Shang, Rui Huang, Meiling Zhang, Jiawei Yao, Chaoshe Guo, Yanan Guo